Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Chung Yin Kong

Showing results (1-10 of 118) with videos related to

Pageof 12
Sort By:
Journal of the American Chemical Society|December 22, 2005
Simulations of stochastic sensing of proteinsChung Yin Kong, M Muthukumar
AJR. American Journal of Roentgenology|October 20, 2021
Cost-Effectiveness of Follow-Up Ultrasound for Incidental Thyroid Nodules on CTMark M Hammer, Chung Yin Kong
Radiology. Cardiothoracic Imaging|May 1, 2023
Cost-effectiveness of Follow-up CT for Incidental Ascending Aortic DilatationMark M Hammer, Chung Yin Kong
Radiology. Cardiothoracic Imaging|May 10, 2021
Cost-Effectiveness of Management Algorithms for Lung-RADS Category 4 NodulesMark M Hammer, Sumit Gupta, Chung Yin Kong
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 11, 2009
Calibration of disease simulation model using an engineering approachChung Yin Kong, Pamela M McMahon, G Scott Gazelle
Academic Radiology|September 7, 2020
Factors Influencing the False Positive Rate in CT Lung Cancer ScreeningMark M Hammer, Suzanne C Byrne, Chung Yin Kong
Academic Radiology|June 17, 2020
Performance of Lung Nodule Management Algorithms for Lung-RADS Category 4 LesionsSumit Gupta, Francine L Jacobson, Chung Yin Kong, et al.
Cancer Medicine|November 15, 2018
Patterns and predictors of end-of-life care in older patients with pancreatic cancerRyan D Nipp, Angela C Tramontano, Chung Yin Kong, et al.
JAMA Network Open|October 14, 2020
Cost-effectiveness of Pembrolizumab Plus Axitinib Vs Nivolumab Plus Ipilimumab as First-Line Treatment of Advanced Renal Cell Carcinoma in the USTina R Watson, Xin Gao, Kerry L Reynolds, et al.
Plos Medicine|February 8, 2018
Population impact of lung cancer screening in the United States: Projections from a microsimulation modelSteven D Criss, Deirdre F Sheehan, Lauren Palazzo, et al.
Pageof 12

Showing results (1-10 of 118) with videos related to

Sort By:
Pageof 12
Journal of the American Chemical Society|December 22, 2005
Simulations of stochastic sensing of proteinsChung Yin Kong, M Muthukumar
AJR. American Journal of Roentgenology|October 20, 2021
Cost-Effectiveness of Follow-Up Ultrasound for Incidental Thyroid Nodules on CTMark M Hammer, Chung Yin Kong
Radiology. Cardiothoracic Imaging|May 1, 2023
Cost-effectiveness of Follow-up CT for Incidental Ascending Aortic DilatationMark M Hammer, Chung Yin Kong
Radiology. Cardiothoracic Imaging|May 10, 2021
Cost-Effectiveness of Management Algorithms for Lung-RADS Category 4 NodulesMark M Hammer, Sumit Gupta, Chung Yin Kong
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|November 11, 2009
Calibration of disease simulation model using an engineering approachChung Yin Kong, Pamela M McMahon, G Scott Gazelle
Academic Radiology|September 7, 2020
Factors Influencing the False Positive Rate in CT Lung Cancer ScreeningMark M Hammer, Suzanne C Byrne, Chung Yin Kong
Academic Radiology|June 17, 2020
Performance of Lung Nodule Management Algorithms for Lung-RADS Category 4 LesionsSumit Gupta, Francine L Jacobson, Chung Yin Kong, et al.
Cancer Medicine|November 15, 2018
Patterns and predictors of end-of-life care in older patients with pancreatic cancerRyan D Nipp, Angela C Tramontano, Chung Yin Kong, et al.
JAMA Network Open|October 14, 2020
Cost-effectiveness of Pembrolizumab Plus Axitinib Vs Nivolumab Plus Ipilimumab as First-Line Treatment of Advanced Renal Cell Carcinoma in the USTina R Watson, Xin Gao, Kerry L Reynolds, et al.
Plos Medicine|February 8, 2018
Population impact of lung cancer screening in the United States: Projections from a microsimulation modelSteven D Criss, Deirdre F Sheehan, Lauren Palazzo, et al.
Pageof 12